PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩300 per share · Prices as of the 2026-10-02 close
Woojin holds a domestic monopoly in nuclear power plant instrumentation and carries SMR growth expectations, but its quarterly earnings show pronounced volatility.
Woojin locally develops and exclusively supplies four core nuclear instruments including in-core instrumentation (ICI), backed by high entry barriers from safety certification requirements.
2025 revenue hit a record KRW 150.3 billion, yet operating profit and net income both declined, squeezing margins.
Earnings surged in 3Q25 before swinging to a net loss in 4Q25, illustrating quarter-to-quarter volatility that makes single-quarter trend reading difficult.
Participation in national SMR R&D projects and rising HBM/AI-driven demand for semiconductor temperature sensors are cited as new growth drivers.
The company presented a target of maintaining a dividend payout ratio above 40% in its '2026 Value-Up Plan.'
Founded in 1980, Woojin is an industrial instrumentation specialist that established Korea's first dedicated metrology research institute in 1987 to lead standardization and localization of measurement equipment.
Its core business is nuclear power plant instrumentation, where it holds an exclusive domestic supply position for replacement parts at operating reactors.
In-core instrumentation (ICI) units are installed at roughly 45 units per OPR1000 reactor and about 61-62 units per APR1400 reactor, generating recurring replacement demand on a typical two-to-four-year cycle.
Revenue is reportedly split roughly as 66.5% instrumentation and equipment, 23.9% nuclear equipment, and 9.6% systems.
Beyond nuclear instrumentation, the company has expanded into semiconductor and industrial temperature sensors, steel industry automation equipment, and condition monitoring systems (CMS), where it is said to hold a meaningful market share.
Its main subsidiary, Woojin Entech, handles maintenance services for nuclear and thermal power plants, with Woojin as its controlling shareholder. The nuclear instrumentation segment features high switching costs because safety and reliability verification takes years, favoring incumbents with long track records.
More recently, the company has developed proprietary reactor vibration assessment technology, expanding its technical scope and exploring potential entry into overseas nuclear markets.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩34.9B | ₩3.8B | 11.0% |
| 2025Q3 | ₩47.6B | ₩9.8B | 20.7% |
| 2025Q4 | ₩40.7B | ₩1.2B | 2.9% |
| 2026Q1 | ₩37.2B | ₩5B | 13.4% |
| 2026Q2 | ₩30.9B | ₩800M | 2.6% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2022 | ₩124.1B | ₩11.9B | ₩9.5B | 9.6% | 6.1% | 28.6% |
| 2023 | ₩129.1B | ₩15.4B | ₩11.7B | 11.9% | 6.9% | 21.8% |
| 2024 | ₩140.7B | ₩16.1B | ₩13.6B | 11.4% | 7.2% | 19.0% |
| 2025 | ₩150.4B | ₩14.2B | ₩8.7B | 9.4% | 4.4% | 23.2% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-21
Annual revenue rose steadily from KRW 124.1 billion in 2022 to KRW 129.1 billion in 2023, KRW 140.7 billion in 2024, and KRW 150.4 billion in 2025.
Operating profit, however, rose from KRW 15.4 billion in 2023 to KRW 16.1 billion in 2024 before falling to KRW 14.2 billion in 2025, with the operating margin declining from 11.4% in 2024 to 9.4% in 2025.
Net income attributable to owners improved from KRW 11.7 billion in 2023 to KRW 13.6 billion in 2024, then retreated to KRW 8.7 billion in 2025, marking a year where revenue growth coincided with profitability softening.
The quarterly pattern is even more pronounced: 2Q25 revenue of KRW 34.9 billion, operating profit of KRW 3.8 billion, and owners' net income of KRW 1.4 billion jumped to KRW 47.6 billion, KRW 9.8 billion, and KRW 9.0 billion respectively in 3Q25.
That was followed by 4Q25, where revenue held at KRW 40.7 billion but operating profit fell to KRW 1.2 billion and owners' net income swung to a loss of KRW 0.9 billion. 1Q26 recovered to revenue of KRW 37.2 billion, operating profit of KRW 5.0 billion, and owners' net income of KRW 4.0 billion, before 2Q26 eased again to revenue of KRW 30.9 billion, operating profit of KRW 0.8 billion, and owners' net income of KRW 1.3 billion.
This quarterly unevenness closely tracks the delivery timing of large nuclear instrumentation supply contracts, which concentrate revenue and profit in specific quarters.
In past earnings commentary, the company attributed quarterly profit swings mainly to increases in deliveries of in-core neutron detectors and control rod position transmitters, along with improved results at a subsidiary.
South Korea's nuclear power sector is in a phase of recovering utilization rates and expanded new-build and continued-operation plans, with the government having stated a policy to raise nuclear utilization.
Woojin holds an exclusive localized supply position for core instrumentation used in Korea's standard reactor designs (OPR1000, APR1400), giving it direct exposure to expanding nuclear operations and rising replacement demand from aging equipment.
Korea's 11th Basic Plan for Electricity Supply and Demand incorporated SMRs as a major generation asset for the first time, a development cited as accelerating domestic SMR commercialization discussions.
Woojin is participating in Korea's innovative small modular reactor (i-SMR) development program to build SMR instrumentation technology, and reports indicate its key customer Doosan Enerbility is advancing construction of a dedicated SMR factory.
Internationally, analysts note that if the Team Korea consortium's Czech nuclear project (including Dukovany units 5 and 6) is completed and expanded, it could have spillover effects across the domestic nuclear equipment and instrumentation supply chain.
In the semiconductor segment, rising temperature sensor demand tied to HBM and AI data center expansion is cited as a growth pillar for Woojin's non-nuclear business.
On the competitive front, high certification and verification barriers in nuclear instrumentation limit new entrants, a dynamic that some observers say could sustain Woojin's exclusive position for an extended period.
In its '2026 Value-Up Plan,' the company outlined three pillars: expanding the share of high-value-added revenue in core businesses, investing in SMR-related R&D, and maintaining a dividend payout ratio above 40%.
In practice, 2025 interim and year-end dividends totaled KRW 6.0 billion, up 21% year over year, which the company said corresponds to a payout ratio of roughly 69%.
In the SMR segment, the company said it continues R&D targeting core instrumentation and components under national research programs to prepare for a first-mover position in the emerging market.
The nuclear instrumentation business has historically secured revenue visibility through periodic supply contracts with Korea Hydro & Nuclear Power, including an in-core instrumentation (ICI) purchase contract reportedly covering 2026 standard reactor overhaul volumes with a contract period running into November 2026.
Semiconductor temperature sensors are cited as a segment where demand could improve on the back of expanding domestic chipmaker production and rising AI server/HBM demand.
That said, the timing and scale at which these growth drivers translate into actual revenue will depend on external variables such as new reactor construction schedules, SMR commercialization timing, and customer investment decisions, warranting continued monitoring through future order and supply contract disclosures.
Over recent years, the share price has moved across a wider range than its historical trading band, reflecting a combination of nuclear/SMR policy expectations and earnings volatility.
With owners' net income declining from 2024 to 2025, current market valuation could be read as pricing in a degree of expected earnings recovery.
The price-to-book ratio tends to trade at a premium to net asset value, which can be interpreted as partly reflecting the company's monopoly position in nuclear instrumentation and expectations around its SMR business.
The company's stated policy of maintaining a dividend payout ratio above 40% is a relevant reference point for shareholder returns, though actual dividend attractiveness will depend on the share price level and future dividend decisions.
On the balance sheet side, the debt ratio remains relatively low, keeping stability metrics comparatively favorable.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-21
Woojin has localized and exclusively supplies core instrumentation used in Korea's standard reactors, and long safety verification cycles make supplier switching practically difficult.
Components like in-core instrumentation generate recurring replacement demand on a two-to-four-year cycle, forming a repeatable revenue base. If domestic nuclear utilization rises alongside aging equipment replacement, instrumentation demand could scale accordingly.
Woojin is participating in Korea's innovative small modular reactor (i-SMR) development program to build instrumentation technology, potentially linking to key customer Doosan Enerbility's SMR factory push.
Policy support has also strengthened, with SMRs incorporated into the government's electricity supply plan for the first time. These developments carry potential to become the next growth pillar for the instrumentation business.
The company explicitly committed to maintaining a dividend payout ratio above 40% in its 2026 Value-Up Plan. In 2025, it paid a total dividend of KRW 6.0 billion, up 21% year over year, putting the policy into practice. Whether this shareholder return stance continues alongside a stable balance sheet is a point worth watching.
Woojin's results show large swings because equipment deliveries tend to concentrate in specific quarters. A prime example is the surge in 3Q25 results giving way to a net loss in 4Q25. This unevenness makes it difficult to read trends from a single quarter's results.
2025 revenue hit a record high, but operating profit fell year over year and the operating margin declined from 11.4% to 9.4%. Owners' net income also decreased versus 2024, showing that revenue growth did not directly translate into improved profitability. This could reflect cost structure or product mix changes weighing on margins.
Woojin's share price has been observed to react sensitively to nuclear/SMR-themed news flow. With a relatively small market capitalization, it is exposed to greater volatility from theme-driven inflows and outflows. This implies the share price can move independently of underlying fundamentals at times.
Nuclear policy is an area subject to shifts depending on political transitions or changes in public opinion. During past anti-nuclear policy periods, nuclear utilization rates and related corporate earnings were affected.
The continuity of new nuclear policies, including SMRs, is a key variable for Woojin's medium- to long-term business outlook.
Woojin's nuclear instrumentation revenue depends on individual supply contracts with a small number of buyers, primarily Korea Hydro & Nuclear Power. Delays in contract renewal or reduced order volumes could directly affect revenue. Reliance on Doosan Enerbility in the SMR segment carries a similar type of risk.
As shown by the 2025 operating margin decline, rising costs for raw materials and labor can pressure margins. Instrument manufacturing relies on precision components and skilled labor, making it relatively sensitive to cost fluctuations. If cost management issues persist, revenue growth may continue to fail to translate into profit growth.
Check whether a follow-on contract is signed after the expiration (November 8, 2026) of the second in-core instrumentation (ICI) purchase supply contract with Korea Hydro & Nuclear Power.
The disclosure of 3Q26 results (quarterly report) will be a point to check whether quarterly earnings unevenness continues and how revenue trends in the nuclear and temperature sensor segments evolve.
Monitoring progress on key customer Doosan Enerbility's dedicated SMR factory construction can help gauge how concretely Woojin's SMR component supply opportunities materialize.
Tracking whether follow-on contracts and equipment orders materialize for the Team Korea consortium's Czech nuclear project (including Dukovany) can help assess how the overseas nuclear spillover effect is actually realized.
Woojin holds an exclusive supply position for core instrumentation used in Korea's standard nuclear power plants, stemming from entry barriers built on years of accumulated safety verification track record. 2025 revenue reached a record high, but operating profit and owners' net income both declined, reflecting clear margin pressure, while quarterly results showed a sharp surge in 3Q followed by a swing to a net loss in 4Q.
Participation in national SMR R&D projects, potential supply ties to Doosan Enerbility, and rising HBM/AI-driven demand for semiconductor temperature sensors are cited as pillars of a medium- to long-term growth narrative.
The company formalized a policy of maintaining a dividend payout ratio above 40% and expanding SMR investment through its 2026 Value-Up Plan, and it followed through with an expanded dividend in 2025.
That said, the structural feature where revenue growth does not automatically translate into profit improvement, along with dependence on a limited number of customers and contracts, are factors that warrant continued attention.
Going forward, contract renewals for instrumentation supply, progress on the SMR business, and whether quarterly earnings volatility persists will likely remain the key observation points for understanding this stock.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.